BASF Canada Receives Registration of PRIAXOR(R) Fungicide

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
BASF Canada Receives Registration of PRIAXOR(R) Fungicide in Western Canada

MISSISSAUGA, ON--(Marketwired - Jun 11, 2014) - BASF Canada is delivering a new fungicide for disease management and plant health benefits to growers across Western Canada. With the registration of PRIAXOR ® fungicide, the unique active XEMIUM ® will be available on a wider range of crops in the 2015 growing season.

PRIAXOR is the next installment in the BASF fungicide portfolio and delivers the unique AgCelence ® benefits growers have come to trust in HEADLINE ® . These benefits include broad-spectrum disease control, increased growth efficiency, and better management of minor plant stress. This is often seen through plants that are taller, with greener, larger leaves and stronger stems and leads to increased crop potential.

"PRIAXOR is a game changer in the fungicide market, giving growers more continuous and consistent disease control," said Jason Leitch, Fungicide Brand Manager at BASF. "It now offers canola growers the two modes of action working together to control blackleg to build a stronger, healthier canola plant."

The fungicide contains the active ingredient XEMIUM, first seen in the pulse fungicide PRIAXOR DS. XEMIUM is a Group 7, SDHI fungicide that complements the Group 11 active ingredient, pyraclostrobin. It delivers unique mobility characteristics for better penetration and movement throughout the leaf. It also forms depots of the active ingredient on the leaf's surface to deliver a consistent supply to the plant.

PRIAXOR is a multiple-mode-of-action product that provides growers a new tool in their integrated disease resistance management strategy. It will be available for sale in Western Canada for the 2015 season for use on canola, pulses, corn, soybeans and flax.

PRIAXOR, XEMIUM and AgCelence are registered trade-marks of BASF SE; HEADLINE is a registered trade-mark of BASF Corporation; all used with permission by BASF Canada Inc. PRIAXOR and/or HEADLINE should be used in a preventative disease control program.

© 2014 BASF Canada Inc.

BASF - The Chemical Company

BASF Canada, located in Mississauga, Ontario is a subsidiary of BASF SE, and an affiliate of BASF Corporation. BASF Corporation, headquartered in Florham Park, New Jersey, is the North American affiliate of BASF SE, Ludwigshafen, Germany. BASF has nearly 17,000 employees in North America, and had sales of $19.3 billion in 2013. For more information about BASF's North American operations, visit www.basf.us . To find out more about BASF's activities in Canada visit www.basf.ca or follow us on twitter: www.twitter.com/basfcanada .

BASF is the world's leading chemical company: The Chemical Company. Its portfolio ranges from chemicals, plastics, performance products and crop protection products to oil and gas. We combine economic success with environmental protection and social responsibility. Through science and innovation, we enable our customers in nearly every industry to meet the current and future needs of society. Our products and solutions contribute to conserving resources, ensuring nutrition and improving quality of life. We have summed up this contribution in our corporate purpose: We create chemistry for a sustainable future. BASF had sales of about EUR74 billion in 2013 and over 112,000 employees as of the end of the year. Further information on BASF is available on the Internet at www.basf.com

For more information contact: Christina Stroud BASF Canada Inc. Tel: (289) 360-6062 E-mail: Email Contact Jo Ann Robinson ON Communication Tel: (519) 963-1946 E-mail: Email Contact

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 184

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 223

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 222

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
HiTHIUM Joins Cambridge to Boost Global Energy Storage

Updated Category News Views 341

HiTHIUM and Cambridge's New Energy Venture There's a big splash coming out of Xiamen, folks. HiTHIUM, a heavyweight in the energy storage sector, has decided to team up with the University of Cambridge. They inked a deal aiming to bridge the academic ivory tower with industrial grit, focusing on long-duration energy storage. It was all sealed during the Global Energy...

Continue Reading
Ecopetrol Sidesteps Hefty Fines After Investigation Closure

Updated Category News Views 174

Colombian Watchdog Gives Ecopetrol a Pass It's like dodging a bullet in a duel at high noon. The Superintendency of Industry and Commerce (SIC) has finally closed its investigation into Ecopetrol S.A. and its subsidiaries, CENIT and OCENSA, after a probe two years in the making. The stakes were sky-high, folks. We're talkin' about just shy of 530 billion Colombian pesos...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 136

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
Greenberg Traurig's Brad Kaufman: A Mentor of Resolute Impact

Updated Category News Views 300

A Milestone for Mentorship at Greenberg Traurig In the often cutthroat jungle of law, finding someone who actually gives a damn about you is as rare as finding a unicorn. Yet, there it is—Brad Kaufman, at the helm of Greenberg Traurig's professional development, proving that mentorship can be more than just a checkbox on a quarterly review. Award for Exceptional...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 106

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 136

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 153

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading

Top 5 Most Recently Viewed Articles

CJ BIO's Bold Steps for Sustainable Animal Nutrition

Updated Category News Views 558

Breaking New Ground in Animal Nutrition Picture this: industry big wigs and farmers alike, all rubbing elbows at EuroTier 2026, the grand meeting ground for animal nutrition's future. This is where CJ BIO is flexing its muscles, not by just tossing ingredients into the mix, but by revolutionizing them under the banner "Feed Intelligence for Sustainable Performance." Now,...

Continue Reading
ParaZero Technologies Achieves Nasdaq Compliance Milestone

Updated Category News Views 130

ParaZero Technologies Regains Compliance with Nasdaq Standards Recent developments in the aerospace sector have highlighted the impressive strides made by ParaZero Technologies Ltd. (Nasdaq: PRZO), an innovator in safety systems for drones and urban air mobility vehicles. The company has reached a significant milestone, regaining compliance with Nasdaq’s minimum bid...

Continue Reading
Revolutionizing Semiconductor Design with AI Integration

Updated Category News Views 389

Ricursive Intelligence Launches Groundbreaking AI Lab Ricursive Intelligence is setting a new standard in semiconductor design with the introduction of its innovative AI lab. This initiative aims to seamlessly blend artificial intelligence with chip creation to expedite progress within the tech landscape. Major Funding and Valuation Boost The company recently raised an...

Continue Reading
Craneware plc Publishes a Key Trading Disclosure Notice

Updated Category News Views 219

Introduction to Craneware plc's Trading Disclosure Craneware plc, a prominent player in the healthcare technology space, has officially announced a significant trading disclosure following the rules established in the Takeover Code. This notification serves as an important communication to stakeholders about recent trading activities that involve exempt principal traders...

Continue Reading
Stocks to Consider Amidst Global Market Uncertainty

Updated Category News Views 150

The Current Market Landscape As geopolitical tensions rise, markets are experiencing undercurrents of uncertainty. Recent tariff threats have sent ripples through global financial markets, particularly affecting investor confidence in stocks. The atmosphere is becoming increasingly cautious, with many investors wondering which stocks might shield their portfolios during...

Continue Reading